CSIMarket



Abbott Laboratories  (ABT)
Other Ticker:  
 
 

ABT's Net Income Growth by Quarter and Year

Abbott Laboratories's Net Income results by quarter and year




ABT Net Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 1,989.00 2,162.00 1,049.00
III Quarter September - 2,100.00 1,232.00 960.00
II Quarter June - 1,189.00 537.00 1,006.00
I Quarter March 2,447.00 1,793.00 564.00 672.00
FY   2,447.00 7,071.00 4,495.00 3,687.00



ABT Net Income first quarter 2022 Y/Y Growth Comment
Abbott Laboratories achieved in the first quarter 2022, above Company average Net Income growth of 36.48% year on year, to $ 2,447.00 millions.

Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 18 other companies have achieved higher Net Income growth. While Abbott Laboratories' s Net Income rise of 36.48% ranks overall at the positon no. 636 in the first quarter 2022.




ABT Net Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - -8 % 106.1 % 60.4 %
III Quarter September - 70.45 % 28.33 % 70.52 %
II Quarter June - 121.42 % -46.62 % 37.24 %
I Quarter March 36.48 % 217.91 % -16.07 % 60.77 %
FY   - 57.31 % 21.91 % 55.7 %

Financial Statements
Abbott Laboratories's first quarter 2022 Net Income $ 2,447.00 millions ABT's Income Statement
Abbott Laboratories's first quarter 2021 Net Income $ 1,793.00 millions Quarterly ABT's Income Statement
New: More ABT's historic Net Income Growth >>


ABT Net Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -5.29 % 75.49 % 9.27 %
III Quarter September - 76.62 % 129.42 % -4.57 %
II Quarter June - -33.69 % -4.79 % 49.7 %
I Quarter March 23.03 % -17.07 % -46.23 % 2.75 %
FY (Year on Year)   - 57.31 % 21.91 % 55.7 %




Net Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #19
Healthcare Sector #40
Overall #636

Net Income Y/Y Growth Statistics
High Average Low
540.81 % 28.43 % -86.21 %
(Sep. 30, 2012)   (Mar 31 2016)
Net Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #19
Healthcare Sector #40
Overall #636
Net Income Y/Y Growth Statistics
High Average Low
540.81 % 28.43 % -86.21 %
(Sep. 30, 2012)   (Mar 31 2016)

Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Abbott Laboratories's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
434 % 16.85 % -84.39 %
(Dec 31 2011)  


ABT's I. Quarter Q/Q Net Income Comment
Abbott Laboratories achieved in the I. Quarter 2022 above company average sequential Net Income jump of 23.03%, to $ 2,447.00 millions, from $1,989.00 millions in the forth quarter.
Major Pharmaceutical Preparations company is impressively improving, with recording better then normal growth, but also improving pace.

Within Major Pharmaceutical Preparations industry 14 other companies have achieved higher Net Income quarter on quarter growth. While Abbott Laboratories's Net Income growth quarter on quarter, overall rank is 760.


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #15
Healthcare Sector #38
Overall #760
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #15
Healthcare Sector #38
Overall #760
Net Income Q/Q Growth Statistics
High Average Low
434 % 16.85 % -84.39 %
(Dec 31 2011)  


ABT's I. Quarter Q/Q Net Income Comment
Abbott Laboratories achieved in the I. Quarter 2022 above company average sequential Net Income jump of 23.03%, to $ 2,447.00 millions, from $1,989.00 millions in the forth quarter.
ABT is going from strength to strength, with reporting higher then average increase, but also accelerating speed.

Within Major Pharmaceutical Preparations industry 14 other companies have achieved higher Net Income quarter on quarter growth. While Abbott Laboratories's Net Income growth quarter on quarter, overall rank is 760.


Abbott Laboratories's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Net Income 12 Months Ending $ 7,725.00 $ 7,071.00 $ 7,244.00 $ 6,376.00 $ 5,724.00
Y / Y Net Income Growth (TTM) 34.96 % 57.31 % 114.19 % 105.02 % 59.93 %
Year on Year Net Income Growth Overall Ranking # 903 # 263 # 424 # 529 # 526
Seqeuential Net Income Change (TTM) 9.25 % -2.39 % 13.61 % 11.39 % 27.34 %
Seq. Net Income Growth (TTM) Overall Ranking # 861 # 951 # 836 # 1200 # 277




Cumulative Net Income growth Comment
Assuming the Abbott Laboratories's fiscal year would have ended in Mar 31 2022, Abbott Laboratories would have reprted above average annual Net Income rise of 34.96% year on year, of $ 7,725 millions.
This marks a slow-down of the companys growth trends and from the 57.31% increase in Dec 31 2021.

In the Healthcare sector 55 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 263 to 903.

Net Income TTM Q/Q Growth Statistics
High Average Low
167.27 %
5.3 %
-77.32 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 21
Healthcare Sector # 56
Overall # 903

Net Income TTM Y/Y Growth Statistics
High Average Low
450.84 %
29.9 %
-69.98 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 21
Sector # 63
S&P 500 # 861
Cumulative Net Income growth Comment
Assuming the Abbott Laboratories's fiscal year would have ended in Mar 31 2022, Abbott Laboratories would have reprted above average annual Net Income rise of 34.96% year on year, of $ 7,725 millions.
This marks a slow-down of the companys growth trends and from the 57.31% increase in Dec 31 2021.

In the Healthcare sector 55 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 263 to 903.

Net Income TTM Q/Q Growth Statistics
High Average Low
167.27 %
5.3 %
-77.32 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 21
Healthcare Sector # 56
Overall # 903

Net Income TTM Y/Y Growth Statistics
High Average Low
450.84 %
29.9 %
-69.98 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 21
Sector # 63
S&P 500 # 861




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
ABT's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for ABT's Competitors
Net Income Growth for Abbott Laboratories's Suppliers
Net Income Growth for ABT's Customers

You may also want to know
ABT's Annual Growth Rates ABT's Profitability Ratios ABT's Asset Turnover Ratio ABT's Dividend Growth
ABT's Roe ABT's Valuation Ratios ABT's Financial Strength Ratios ABT's Dividend Payout Ratio
ABT's Roa ABT's Inventory Turnover Ratio ABT's Growth Rates ABT's Dividend Comparisons



Companies with similar Net Income increase for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Net Income for the quarter ending Mar 31 2022
Repligen Corp59.47%$ 59.470 millions
Conmed Corporation51.88%$ 51.876 millions
Becton Dickinson And Company51.33%$ 51.333 millions
Iqvia Holdings Inc 49.77%$ 49.770 millions
Charles River Laboratories International inc 48.94%$ 48.942 millions
Co diagnostics Inc.48.31%$ 48.305 millions
Phibro Animal Health Corp45.46%$ 45.457 millions
Abcellera Biologics Inc 43.81%$ 43.808 millions
Medpace Holdings Inc 41.58%$ 41.576 millions
Eli Lilly And Company40.40%$ 40.404 millions
Abbott Laboratories36.48%$ 36.475 millions
Merck and Co Inc 35.37%$ 35.374 millions
Bio techne Corp32.47%$ 32.470 millions
The Pennant Group Inc 26.83%$ 26.835 millions
Abbvie Inc 26.39%$ 26.385 millions
Tenet Healthcare Corp26.13%$ 26.126 millions
Glucotrack Inc.20.91%$ 20.907 millions
Syneos Health Inc 19.24%$ 19.244 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DBRM's Profile

Stock Price

DBRM's Financials

Business Description

Fundamentals

Charts & Quotes

DBRM's News

Suppliers

DBRM's Competitors

Customers & Markets

Economic Indicators

DBRM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071